Correction to: Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT.
Adv Ther
; 41(7): 3014-3015, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-38787464
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Adv Ther
Journal subject:
TERAPEUTICA
Year:
2024
Document type:
Article
Affiliation country:
Australia